{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:09:42Z","timestamp":1791673782918,"version":"4.3.4"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.1001\/jamainternmed.2022.0375","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T11:34:08Z","timestamp":1648467248000},"page":"522","source":"Crossref","is-referenced-by-count":69,"title":["Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders"],"prefix":"10.1001","volume":"182","author":[{"given":"Loreen","family":"Straub","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Wisner","sequence":"additional","affiliation":[{"name":"The Asher Center for the Study and Treatment of Depressive Disorders, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Gray","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page B.","family":"Pennell","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Lester","sequence":"additional","affiliation":[{"name":"Center for the Study of Children at Risk, Departments of Psychiatry and Pediatrics, Alpert Medical School of Brown University, and Women and Infants Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[{"name":"Lurie Center for Autism, Massachusetts General Hospital, Lexington"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Suarez","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Zakoul","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mogun","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista F.","family":"Huybrechts","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"16","key":"ioi220010r1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jama.2010.453","article-title":"Questionable antipsychotic prescribing remains common, despite serious risks.","volume":"303","author":"Kuehn","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"ioi220010r2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995-2008.","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"ioi220010r3","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1176\/appi.ps.201600408","article-title":"Antipsychotic medication use among publicly insured pregnant women in the United States.","volume":"68","author":"Park","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"2","key":"ioi220010r4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","article-title":"Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.","volume":"16","author":"Toh","year":"2013","journal-title":"Arch Womens Ment Health"},{"issue":"8","key":"ioi220010r5","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry"},{"key":"ioi220010r6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.schres.2019.11.019","article-title":"Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997-2011.","volume":"215","author":"Anderson","year":"2020","journal-title":"Schizophr Res"},{"issue":"12","key":"ioi220010r7","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1176\/appi.ajp.2018.18010098","article-title":"Risk of major malformations in infants following first-trimester exposure to quetiapine.","volume":"175","author":"Cohen","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"4","key":"ioi220010r8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40263-018-0517-5","article-title":"The safety of second-generation antipsychotics during pregnancy: a clinically focused review.","volume":"32","author":"Damkier","year":"2018","journal-title":"CNS Drugs"},{"issue":"1","key":"ioi220010r9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00228-019-02769-z","article-title":"Second-generation antipsychotics and pregnancy complications.","volume":"76","author":"Ellfolk","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"ioi220010r10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations.","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"ioi220010r11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.","volume":"66","author":"McKenna","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"ioi220010r12","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1111\/bcp.v87.11","article-title":"Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: A systematic review and meta-analysis.","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"ioi220010r13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S1092852916000699","article-title":"Neurodevelopmental outcomes in infants exposed in utero to antipsychotics: a systematic review of published data.","volume":"22","author":"Gentile","year":"2017","journal-title":"CNS Spectr"},{"issue":"1","key":"ioi220010r14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1124\/pr.56.1.5","article-title":"Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects.","volume":"56","author":"Costa","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"3","key":"ioi220010r15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0091-3057(02)00727-X","article-title":"Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats.","volume":"72","author":"Rosengarten","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"ioi220010r16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0161-813X(01)00092-4","article-title":"New insights and new issues in developmental neurotoxicology.","volume":"23","author":"Olney","year":"2002","journal-title":"Neurotoxicology"},{"issue":"1","key":"ioi220010r17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/npp.2009.115","article-title":"Normal development of brain circuits.","volume":"35","author":"Tau","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"ioi220010r18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pnpbp.2007.09.005","article-title":"Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.","volume":"32","author":"Zuo","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"ioi220010r19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/ijnp\/pyy073","article-title":"Prenatal exposure to antipsychotics disrupts the plasticity of dentate neurons and memory in adult male mice.","volume":"22","author":"Wang","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"ioi220010r20","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","article-title":"Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age.","volume":"181","author":"Wang","year":"2021","journal-title":"JAMA Intern Med"},{"key":"ioi220010r21","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2021-300311","article-title":"Antipsychotic use in pregnancy and risk of attention\/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study.","author":"H\u00e1lfd\u00e1narson","year":"2021","journal-title":"Evid Based Ment Health"},{"issue":"6","key":"ioi220010r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067405","article-title":"Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations.","volume":"8","author":"Palmsten","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"ioi220010r23","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/pds.v28.9","article-title":"Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.","volume":"28","author":"MacDonald","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"ioi220010r24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0811","article-title":"Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009-2017.","volume":"144","author":"Zablotsky","year":"2019","journal-title":"Pediatrics"},{"issue":"2","key":"ioi220010r26","first-page":"1","article-title":"Mental health surveillance among children--United States, 2005-2011.","volume":"62","author":"Perou","year":"2013","journal-title":"MMWR Suppl"},{"issue":"12","key":"ioi220010r27","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/pds.v30.12","article-title":"Validity of claims-based algorithms to identify neurodevelopmental disorders in children.","volume":"30","author":"Straub","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ioi220010r28","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.3815","article-title":"Neurodevelopmental disorders among publicly or privately insured children in the United States.","author":"Straub","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"ioi220010r29","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients.","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"Pt A","key":"ioi220010r32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited.","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"ioi220010r33","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights.","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"4","key":"ioi220010r34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"3","key":"ioi220010r35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/pto.2006.98.issue-3","article-title":"Comparison of dynamic treatment regimes via inverse probability weighting.","volume":"98","author":"Hern\u00e1n","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"ioi220010r36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.0006-341X.2000.00779.x","article-title":"Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.","volume":"56","author":"Robins","year":"2000","journal-title":"Biometrics"},{"issue":"1","key":"ioi220010r37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios.","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"issue":"9","key":"ioi220010r38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00787-018-1177-1","article-title":"Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis.","volume":"27","author":"Poels","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ioi220010r39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA\u2019s statement on P values: context, process, and purpose.","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"issue":"7748","key":"ioi220010r40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Scientists rise up against statistical significance.","volume":"567","author":"Amrhein","year":"2019","journal-title":"Nature"},{"issue":"7","key":"ioi220010r41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.","volume":"60","author":"Potkin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"ioi220010r42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/MOP.0000000000000389","article-title":"Long-term neurodevelopmental benefits of breastfeeding.","volume":"28","author":"Bar","year":"2016","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"ioi220010r43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/bfm.2017.0122","article-title":"The science of breastfeeding and brain development.","volume":"12","author":"Brown Belfort","year":"2017","journal-title":"Breastfeed Med"},{"key":"ioi220010r44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"ioi220010r45","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/(ISSN)1099-1557","article-title":"Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy.","volume":"28","author":"Huybrechts","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ioi220010r25","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"ioi220010r30","unstructured":"US Department of Agriculture\u2019s Economic Research Service. County-level data sets. Accessed March 18, 2020. https:\/\/www.ers.usda.gov\/data-products\/county-level-data-sets\/download-data\/"},{"key":"ioi220010r31","unstructured":"US Department of Housing and Urban Development\u2019s Office of Policy Development and Research. HUD-USPS ZIP Crosswalk Files. Accessed March 18, 2020. https:\/\/www.huduser.gov\/portal\/datasets\/usps_crosswalk.html#data"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2790391\/jamainternal_straub_2022_oi_220010_1650900270.8848.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:02:59Z","timestamp":1651489379000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2790391"}},"subtitle":["A National Birth Cohort Study"],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2022.0375","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}